Inhibition of nuclear factor‐kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion
Authors:
Open Access
- 2 February 2011
- journal article
- Published by Wiley in Cancer Science
- Vol. 102 (5) , 1052-1058
Abstract
Currently, patients with peritoneal dissemination of gastric cancer must accept a poor prognosis because there is no standard effective therapy. To inhibit peritoneal dissemination it is important to inhibit interactions between extracellular matrices (ECM) and cell surface integrins, which are important for cancer cell adhesion. Although nuclear factor‐kappa B (NF‐κB) is involved in various processes in cancer progression, its involvement in the expression of integrins has not been elucidated. We used a novel NF‐κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), to study whether NF‐κB blocks cancer cell adhesion via integrins in a gastric cancer dissemination model in mice and found that DHMEQ is a potent suppressor of cancer cell dissemination. Dehydroxymethylepoxyquinomicin suppressed the NF‐κB activity of human gastric cancer cells NUGC‐4 and 44As3Luc and blocked the adhesion of cancer cells to ECM when compared with the control. Dehydroxymethylepoxyquinomicin also inhibited expression of integrin (α2, α3, β1) in in vitro studies. In the in vivo model, we injected 44As3Luc cells pretreated with DHMEQ into the peritoneal cavity of mice and performed peritoneal lavage after the injection of cancer cells. Viable cancer cells in the peritoneal cavities were evaluated sequentially by in vivo imaging. In mice injected with DHMEQ‐pretreated cells and lavaged, live cancer cells in the peritoneum were significantly reduced compared with the control, and these mice survived longer. These results indicate that DHMEQ could inhibit cancer cell adhesion to the peritoneum possibly by suppressing integrin expression. Nuclear factor‐kappa B inhibition may be a new therapeutic option for suppressing postoperative cancer dissemination. (Cancer Sci 2011; 102: 1052–1058)Keywords
This publication has 37 references indexed in Scilit:
- Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancerMolecular Cancer, 2010
- Anti-β1 Integrin Antibody Reduces Surgery-Induced Adhesion of Colon Carcinoma Cells to Traumatized Peritoneal SurfacesAnnals of Surgery, 2008
- Distribution of extracellular matrix proteins type I collagen, type IV collagen, fibronectin, and laminin in mouse folliculogenesisHistochemistry and Cell Biology, 2006
- Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, induces apoptosis in multiple myeloma cells in an IκBα-independent mannerMolecular Cancer Therapeutics, 2005
- NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cellsOncogene, 2003
- p53 stabilization is decreased upon NFκB activationCancer Cell, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Composition of the extracellular matrix of the peritoneumJournal of the Society for Gynecologic Investigation, 2001
- Metastatic Dissemination of Human Ovarian Epithelial Carcinoma Is Promoted by α2β1-Integrin-Mediated Interaction with Type I CollagenInvasion and Metastasis, 1998
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992